May 23- 2014 – The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. Dalvance is intended to treat acute bacterial skin and skin structure infections (ABSSSI) caused by …

Dalbavancin (Dalvance): Approved by FDA to treat skin infections Read more »